Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Submitted by
admin
on August 27, 2021 - 10:54am
Source:
Motley Fool
News Tags:
CureVac
Boehringer Ingelheim
MRNA
lung cancer
vaccines
Moderna Therapeutics
BioNTech
Headline:
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
snippet:
Boehringer Ingelheim terminated a partnership with CureVac on an mRNA lung cancer vaccine program.
The cancellation of this deal shouldn't impact other mRNA cancer vaccine programs for Moderna, BioNTech, and other biotech companies.
Do Not Allow Advertisers to Use My Personal information
